lymphoma. Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
Conditions
Interventions
Intervention group: These patients with relapsed lymphoma are candidates for autologous bone marrow transplantation after salvage chemotherapy. Before autologous bone marrow transplantation the BeEAM
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: All the lymphoma patients from 18 to 65 years old that are candidate for autologous stem cell transplant
Exclusion criteria
Exclusion criteria: Not enough harvesting of CD34+ cells
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete remission of lymphoma within 6 months of transplantation. Timepoint: Six months after the transplant. Method of measurement: CT scan,measurement of lactate dehydrogenase and erythrocytes sedimentation rate. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hematologic toxicity. Timepoint: During hospitalization in the bone marrow transplantation ward. Method of measurement: Comlete blood count test.;Post transplant mortality. Timepoint: 100 days post transplant. Method of measurement: Physical examination.;The interval between stem cell infusion and transplantation. Timepoint: During hospitalization in transplantation ward. Method of measurement: Complete blood count test.;Non hematologic toxicity. Timepoint: 6months post transplantation. Method of measurement: Physical examination,liver and renal function tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Elaheh Vafaie
Shiraz University of Medical Sciences
Outcome results
None listed